155 related articles for article (PubMed ID: 33039370)
1. Biopsies of hepatocellular carcinoma with no reticulin loss: an important diagnostic pitfall.
Yasir S; Chen ZE; Said S; Wu TT; Torbenson M
Hum Pathol; 2021 Jan; 107():20-28. PubMed ID: 33039370
[TBL] [Abstract][Full Text] [Related]
2. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
Singhi AD; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson M
Am J Surg Pathol; 2012 May; 36(5):710-5. PubMed ID: 22498821
[TBL] [Abstract][Full Text] [Related]
3. Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma.
Hong H; Patonay B; Finley J
Diagn Pathol; 2011 Feb; 6():15. PubMed ID: 21338527
[TBL] [Abstract][Full Text] [Related]
4. Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum.
Shafizadeh N; Ferrell LD; Kakar S
Mod Pathol; 2008 Aug; 21(8):1011-8. PubMed ID: 18536657
[TBL] [Abstract][Full Text] [Related]
5. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
Swanson BJ; Yearsley MM; Marsh W; Frankel WL
Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients.
Li B; Liu H; Shang HW; Li P; Li N; Ding HG
Afr Health Sci; 2013 Sep; 13(3):703-9. PubMed ID: 24250310
[TBL] [Abstract][Full Text] [Related]
7. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
de Boer WB; Segal A; Frost FA; Sterrett GF
Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
[TBL] [Abstract][Full Text] [Related]
8. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
9. Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas.
Larson BK; Guindi M
Ann Diagn Pathol; 2021 Dec; 55():151833. PubMed ID: 34597957
[TBL] [Abstract][Full Text] [Related]
10. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features.
Choi WT; Kakar S
Adv Anat Pathol; 2018 Jul; 25(4):254-262. PubMed ID: 29649004
[TBL] [Abstract][Full Text] [Related]
11. Fine needle aspiration cytodiagnosis of liver tumors.
Kuo FY; Chen WJ; Lu SN; Wang JH; Eng HL
Acta Cytol; 2004; 48(2):142-8. PubMed ID: 15085744
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.
Yao S; Zhang J; Chen H; Sheng Y; Zhang X; Liu Z; Zhang C
J Histochem Cytochem; 2013 Sep; 61(9):639-48. PubMed ID: 23686365
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of the reticulin stain in the differential diagnosis of liver nodules on fine-needle aspiration biopsy cell block preparations.
Bergman S; Graeme-Cook F; Pitman MB
Mod Pathol; 1997 Dec; 10(12):1258-64. PubMed ID: 9436973
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence-based reticulin proportionate area - a novel histological outcome predictor in hepatocellular carcinoma.
Patil A; Salvatori R; Smith L; Jenkins SM; Cannon A; Hartley CP; Graham RP; Moreira RK
Histopathology; 2023 Oct; 83(4):512-525. PubMed ID: 37387193
[TBL] [Abstract][Full Text] [Related]
15. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
16. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?
Wee A; Nilsson B
Acta Cytol; 2003; 47(1):16-26. PubMed ID: 12585026
[TBL] [Abstract][Full Text] [Related]
17. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Li J; Wei L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
[TBL] [Abstract][Full Text] [Related]
18. Comparing prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins glypican-3, Alpha feto protein and carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients.
Abd El Gawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
J Egypt Natl Canc Inst; 2014 Jun; 26(2):79-85. PubMed ID: 24841158
[TBL] [Abstract][Full Text] [Related]
19. Macroregenerative nodules in cirrhosis are not associated with elevated serum or stainable tissue alpha-fetoprotein.
Theise ND; Fiel IM; Hytiroglou P; Ferrell L; Schwartz M; Miller C; Thung SN
Liver; 1995 Feb; 15(1):30-4. PubMed ID: 7539880
[TBL] [Abstract][Full Text] [Related]
20. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
